Understanding Atherosclerosis Formation and Risks

8 décembre 2025

Crée tes propres fiches en 30 secondes

Colle ton cours, Revizly le transforme en résumé, fiches, flashcards et QCM.

Commencer gratuitement

1. Overview

  • Atherosclerosis is the hardening of medium-large arteries caused by patchy deposits of fatty material (LDL cholesterol) called atheromas or atheromatous plaques.
  • These plaques develop beneath the intima (endothelium), causing arterial lumen narrowing (stenosis) and reduced blood flow (ischemia).
  • The condition evolves slowly, starting with intimal thickening as early as ages 10-20 and symptomatic disease from age 35-40 onwards.
  • Key topics include risk factors, pathogenesis (atherogenesis), plaque progression, types of plaques, complications, and clinical manifestations in heart, brain, and lower limbs.

2. Core Concepts & Key Elements

  • Definition: Atherosclerosis = fatty plaque build-up in artery walls causing lumen narrowing.
  • Development timeline: Early lesions from 10-20 years; symptoms from 35-40 years onwards.
  • Risk factors:
    • Hypercholesterolemia: Total cholesterol > 200 mg/dl, LDL > 160 mg/dl
    • Hypertension: Systolic ≥140 mmHg, Diastolic ≥90 mmHg
    • Smoking
    • Diabetes mellitus: fasting glycemia 70-110 mg/dl normal, hyperglycemia increases risk
    • Others: Age, sex, obesity, inactivity
  • Atherogenesis stages:
    A. Initiation: Endothelial dysfunction; LDL crosses endothelium and oxidizes sub-endothelially
    B. Early lesion: Recruitment of monocytes and T-lymphocytes; monocytes transform into macrophages taking up oxidized LDL forming foam cells (fatty streak)
    C. Fibrous plaque: Foam cells accumulate; VSMC migrate producing collagen and connective matrix forming fibrous cap over lipid/necrotic core
    D. Complicated plaque: Fibrous cap disruption or fissure → coagulation system activation → thrombus formation → vessel obstruction (complete or partial)
  • Plaque types:
    • Stable plaques: collagen-rich, hard, low risk of rupture
    • Unstable plaques: lipid-rich, soft, high risk of fissure/thrombosis
  • Clinical symptoms:
    • Silent until stenosis > 70-75%
    • Chronic progressive ischemia from stable plaques (partial lumen occlusion)
    • Acute ischemia from unstable plaques rupture and thrombus (complete occlusion)
  • Affected organs and clinical syndromes:
    • Heart (coronary arteries): stable angina, acute coronary syndrome (unstable angina, MI)
    • Brain (carotid, intracerebral arteries): TIA, stroke
    • Lower limbs (iliac, femoral, popliteal arteries): intermittent claudication, gangrene

3. High-Yield Facts

  • Atheroma: patchy fatty deposits under endothelium, reduce lumen, cause ischemia
  • LDL cholesterol critical value: >160 mg/dl high risk
  • Hypertension cutoffs: ≥140/90 mmHg
  • Normal fasting glycemia: 70-110 mg/dl
  • Fibrous cap: collagen-rich layer covering necrotic core, key for plaque stability
  • Foam cell: macrophage loaded with oxidized LDL, hallmark of fatty streak
  • Plaque stability related to composition: collagen-rich = stable, lipid-rich = unstable
  • Critical stenosis threshold for symptoms: >70-75% lumen narrowing
  • Thrombus formation caused by fibrous cap rupture → ischemic events
  • Clinical syndromes across vascular beds: angina/MI, TIA/stroke, claudication/gangrene

4. Summary Table

ConceptKey PointsNotes
AtherosclerosisFatty plaque deposits under intima cause arterial narrowingLeads to ischemia
Risk factorsHigh LDL (>160 mg/dl), hypertension (≥140/90), diabetes, smokingMultifactorial etiology
Atherogenesis stagesEndothelial dysfunction → oxidized LDL → foam cells → fibrous plaque → complicated plaqueProgressive plaque growth and complications
Plaque typesStable (collagen-rich), unstable (lipid-rich)Stability underlies symptom onset
Clinical symptomsAsymptomatic until >70-75% stenosis; chronic vs acuteAcute events due to plaque rupture & thrombosis
Affected organsHeart, brain, lower limbsSpecific clinical syndromes

5. Mini-Schema (ASCII)

Atherosclerosis
 ├─ Risk Factors
 │    ├─ High LDL
 │    ├─ Hypertension
 │    ├─ Smoking
 │    └─ Diabetes
 ├─ Atherogenesis
 │    ├─ Initiation: Endothelial dysfunction, LDL oxidation
 │    ├─ Early lesion: Foam cells formation
 │    ├─ Fibrous plaque: VSMC collagen cap formation
 │    └─ Complicated plaque: Cap rupture, thrombus formation
 ├─ Plaque Types
 │    ├─ Stable (collagen-rich)
 │    └─ Unstable (lipid-rich)
 ├─ Clinical Manifestations
 │    ├─ Chronic ischemia (partial stenosis)
 │    └─ Acute ischemia (plaque rupture + thrombosis)
 └─ Affected Organs
      ├─ Heart: Angina, MI
      ├─ Brain: TIA, Stroke
      └─ Lower limbs: Claudication, Gangrene

6. Rapid-Review Bullets

  • Atherosclerosis = fatty deposits (LDL) under endothelium cause arterial stenosis
  • Initial lesions start by ages 10-20, symptoms by 35-40 yrs
  • Hypercholesterolemia defined as total cholesterol >200 mg/dl, LDL >160 mg/dl
  • Hypertension cutoff: ≥140/90 mmHg
  • Diabetes causes hyperglycemia (>110 mg/dl fasting) increasing risk
  • Endothelial dysfunction initiates LDL oxidation and subendothelial trapping
  • Foam cells = macrophages + oxidized LDL; hallmark of fatty streaks
  • Fibrous plaque = VSMC collagen cap over lipid-rich core
  • Fibrous cap rupture activates coagulation → thrombus → vessel occlusion
  • Stable plaques = collagen-rich, less likely to rupture
  • Unstable plaques = lipid-rich, prone to rupture and thrombosis
  • Symptoms arise when artery lumen narrowed >70-75%
  • Chronic ischemia from stable plaques; acute ischemia from thrombus formation
  • Heart involvement: stable angina, acute coronary syndrome (AMI)
  • Brain involvement: TIA and ischemic stroke
  • Lower limb involvement: intermittent claudication, gangrene
  • Prevention targets risk factors: control cholesterol, BP, smoking, diabetes
  • Atherosclerosis progression is slow and silent until significant stenosis occurs